Clinical Trial Update: Study to Test the Efficacy of the Vaccine GSK 249553 in Treating Non-small-cell Lung Cancer After Tumour Removal by Surgery [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating the efficacy of GSK 249553 vaccine in treating non-small cell lung cancer after surgical tumor removal; study completed wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• GSK 249553

Snippet

Sponsor: GlaxoSmithKline | Conditions: Lung Cancer, Non-Small Cell | Phase 2 | Status: COMPLETED | Results posted: 2019-02-25